Table 5

Overall and stratified meta-analyses of the association between COX-2 polymorphisms and risk of hepatocellular carcinoma

ComparisonPopulationNo. included in the studyTest of association*Test of heterogeneity
OR95% CIp ValueModelp ValueI2
COX-2 A-1195G (rs689466)
G allele vs A alleleOverall80.870.75 to 1.020.09R0.00764
Chinese50.840.72 to 0.990.04R0.0265
Non-Chinese31.000.63 to 1.590.99R0.0274
GG vs GA+AAOverall80.720.57 to 0.920.008R0.0452
Chinese50.790.62 to 1.010.06R0.0655
Non-Chinese30.490.30 to 0.780.003F0.660
GG vs AAOverall80.720.53 to 0.970.03R0.0257
Chinese50.710.51 to 0.990.05R0.0266
Non-Chinese30.770.32 to 1.840.56R0.1352
AA vs GA+GGOverall81.050.77 to 1.440.74R<0.00179
Chinese51.230.98 to 1.550.07R0.0657
Non-Chinese30.690.24 to 2.030.51R<0.00190
COX-2 G-765C (rs20417)
C allele vs G alleleOverall61.320.76 to 2.300.33R<0.00188
CC vs GC+GGOverall30.880.16 to 4.750.88R0.00780
CC vs GGOverall30.930.16 to 5.350.94R0.00581
GG vs CC+GCOverall60.480.14 to 1.590.23R<0.00197
COX-2 T+8473C (rs5275)
C allele vs T alleleOverall30.990.86 to 1.140.91F0.670
CC vs CT+TTOverall31.310.83 to 2.070.25F0.370
CC vs TTOverall31.250.78 to 1.980.35F0.330
TT vs CT+CCOverall31.050.89 to 1.240.58F0.570
  • *Mantel–Haenszel estimate was used to give a pooled OR using the fixed-effect models, and a [Bold] indicates p value served as the threshold for statistical significance. DerSimonian–Laird estimate was used for random-effect models.

  • F, fixed-effect model; R, random-effect model.